Paloma Partners Management CO Bristol Myers Squibb CO Transaction History

Paloma Partners Management CO

$3.08 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.26 Million - $1.65 Million	31,190 New	31,190 $1.3 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1.49 Million - $1.78 Million	-30,733 Reduced 41.17%	43,912 $2.25 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $316,658 - $354,073	-5,470 Reduced 6.83%	74,645 $4.33 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $5.1 Million - $5.67 Million	80,115 New	80,115 $5.12 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $2.05 Million - $2.42 Million	29,866 Added 902.57%	33,175 $2.39 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $4,906 - $2.9 Million	-37,739 Reduced 91.94%	3,309 $235,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $2.98 Million - $3.28 Million	41,048 New	41,048 $3.16 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $12.7 Million - $15.2 Million	-206,708 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $11.1 Million - $12.9 Million	206,708 New	206,708 $12.9 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $8.53 Million - $9.29 Million	-137,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.31 Million - $1.47 Million	22,100 Added 19.1%	137,800 $8.7 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.95 Million - $2.21 Million	33,732 Added 41.15%	115,700 $7.18 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $9.6 Million - $10.6 Million	-167,146 Reduced 67.1%	81,968 $4.94 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $13.5 Million - $15.8 Million	246,435 Added 9198.77%	249,114 $14.6 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $547,241 - $795,269	-11,794 Reduced 81.49%	2,679 $150,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $459,916 - $599,919	9,346 Added 182.29%	14,473 $929,000
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $491,512 - $582,759	-11,492 Reduced 69.15%	5,127 $259,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $749,849 - $894,102	16,619 New	16,619 $793,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.24 Million - $1.61 Million	-25,481 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $699,367 - $788,832	12,672 Added 98.93%	25,481 $1.58 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $230,152 - $264,952	-3,841 Reduced 23.07%	12,809 $810,000
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $280,878 - $306,230	-4,686 Reduced 21.96%	16,650 $1.02 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $1.18 Million - $1.36 Million	21,336	21,336 $1.36 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.7 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.98 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.26 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.41 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.45 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account